AU2000275035A1 - Therapeutic and prophylactic drugs of myopia - Google Patents

Therapeutic and prophylactic drugs of myopia

Info

Publication number
AU2000275035A1
AU2000275035A1 AU2000275035A AU7503500A AU2000275035A1 AU 2000275035 A1 AU2000275035 A1 AU 2000275035A1 AU 2000275035 A AU2000275035 A AU 2000275035A AU 7503500 A AU7503500 A AU 7503500A AU 2000275035 A1 AU2000275035 A1 AU 2000275035A1
Authority
AU
Australia
Prior art keywords
myopia
therapeutic
prophylactic drugs
prophylactic
drugs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2000275035A
Inventor
Tricia T. S. Cheng
George C.Y. Chiou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
YONG GUANG PHARMACEUTICAL CO Ltd
Original Assignee
YONG GUANG PHARMACEUTICAL CO L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by YONG GUANG PHARMACEUTICAL CO L filed Critical YONG GUANG PHARMACEUTICAL CO L
Publication of AU2000275035A1 publication Critical patent/AU2000275035A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
AU2000275035A 2000-09-20 2000-09-20 Therapeutic and prophylactic drugs of myopia Abandoned AU2000275035A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2000/000286 WO2002024191A1 (en) 2000-09-20 2000-09-20 Therapeutic and prophylactic drugs of myopia

Publications (1)

Publication Number Publication Date
AU2000275035A1 true AU2000275035A1 (en) 2002-04-02

Family

ID=4574703

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2000275035A Abandoned AU2000275035A1 (en) 2000-09-20 2000-09-20 Therapeutic and prophylactic drugs of myopia

Country Status (3)

Country Link
CN (1) CN1390124A (en)
AU (1) AU2000275035A1 (en)
WO (1) WO2002024191A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2866848C (en) 2002-07-30 2017-01-03 Omeros Corporation Ophthalmologic irrigation solutions and method
AU2013201465B2 (en) 2012-10-24 2016-03-03 Rayner Surgical (Ireland) Limited Stable preservative-free mydriatic and anti-inflammatory solutions for injection
RU2635185C2 (en) * 2013-12-17 2017-11-09 Иван Дмитриевич Захаров Pharmaceutical preparation for prevention and treatment of progressive myopia
TWI809304B (en) 2014-12-01 2023-07-21 奥默羅斯公司 Anti-inflammatory and mydriatic intracameral solutions for inhibition of postoperative ocular inflammatory conditions
WO2017219080A1 (en) * 2016-06-21 2017-12-28 The University Of Newcastle Treatment for myopia
JP7039606B2 (en) * 2018-07-18 2022-03-22 温州医科大学 Treatment of myopia and its application in drug preparation
CA3182439A1 (en) * 2020-06-11 2021-12-16 Andrei V. Tkatchenko Methods and compositions for preventing and treating myopia with s-methyl-l-thiocitrulline, a selective neuronal nitric oxide synthase (nnos) inhibitor, and derivatives thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4461759A (en) * 1983-01-03 1984-07-24 Verex Laboratories, Inc. Constant release rate solid oral dosage formulations of veropamil
US5457093A (en) * 1987-09-18 1995-10-10 Ethicon, Inc. Gel formulations containing growth factors
GB9312204D0 (en) * 1993-06-14 1993-07-28 Zeneca Ltd Therapeutic composition
IT1265665B1 (en) * 1993-06-21 1996-11-22 Fidia Spa PHARMACEUTICAL COMPOSITIONS INCLUDING 8-CHLORO-3-(BETA- DIETHYLAMINOETHYL)-4-METHYL-7-ETHOXYCARBONYLMETHOXY CUMARIN BASE E

Also Published As

Publication number Publication date
WO2002024191A1 (en) 2002-03-28
CN1390124A (en) 2003-01-08

Similar Documents

Publication Publication Date Title
AU2002213357A1 (en) Variant igg3 rituxan r and therapeutic use thereof
AU2001269314A1 (en) Therapeutic and prophylactic use of reduced forms of pharmaceutical compounds
AU7339800A (en) Ophthalmic device and method of manufacture and use
AU7735200A (en) Treatment of tissue by application of energy and drugs
AU2001286940A1 (en) Drug delivering prostheses and methods of use
HUP0301121A3 (en) Topical pharmaceutical formulations and methods of treatment
AU2002315166A1 (en) Sir2alpha-based therapeutic and prophylactic methods
AU7907300A (en) Novel combination of loteprednol and antihistamines
AU7612000A (en) Mono- and bis-indolylquinones and prophylactic and therapeutic uses thereof
AU2001233296A1 (en) Establishing and maintaining therapeutic hypothermia
AU715620C (en) Therapeutic methods and uses
AU2001265253A1 (en) Treatment of hiv using hyperthermia
AU1164601A (en) Therapeutic use and formulation
AU2002252976A1 (en) Hydrazones and their therapeutic use
AU2001256855A1 (en) Preparation for the prevention and treatment of ocular disorders
AUPQ622600A0 (en) Treatment and/or prevention of ocular pain
AU2001259085A1 (en) Treatment of ocular neovascularization and related diseases
AU2002359618A1 (en) Medicinal compositions and therapeutic methods
AU6887101A (en) Copolymers and methods of treating prion-related diseases
AU2000275035A1 (en) Therapeutic and prophylactic drugs of myopia
AU1068101A (en) Transdermal administration of reboxetine
AU2001261375A1 (en) Human caspase-12 materials and methods
AU2001264863A1 (en) Preparation of fagopyritols and uses therefor
AU2001284380A1 (en) Therapeutic and cosmetic uses of heparanases
AU2001267165A1 (en) Prevention and treatment of mycoplasma-associated diseases